FRGT vs NVDA

FRGT exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9 and a catastrophic 95.2% price decline over the last year. The company suffers from negative gross margins (-24.43%), meaning it loses money on every unit sold, which renders traditional valuation metrics like the Graham Number inapplicable. While revenue growth is positive at 30.2%, it is insufficient to offset massive operating losses and a deteriorating liquidity position (Current Ratio 0.94). The stock is currently in a freefall, trading near its 52-week low after a collapse from $69.80.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.